• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子1通过蛋白激酶A信号通路调节有机阴离子转运体3的磷酸化、表达及活性。

Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway.

作者信息

Zhang Jinghui, Yu Zhou, You Guofeng

机构信息

Department of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

出版信息

Acta Pharm Sin B. 2020 Jan;10(1):186-194. doi: 10.1016/j.apsb.2019.05.005. Epub 2019 Jun 5.

DOI:10.1016/j.apsb.2019.05.005
PMID:31993315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6977015/
Abstract

Organic anion transporter 3 (OAT3) plays a vital role in removing a broad variety of anionic drugs from kidney, thus avoiding their possible toxicity in the body. In the current study, we investigated the role of insulin-like growth factor 1 (IGF-1) in the regulation of OAT3. We showed that IGF-1 induced a dose- and time-dependent increase in OAT3 transport activity, which correlated well with an increase in OAT3 expression. The IGF-1-induced increase in OAT3 expression was blocked by protein kinase A (PKA) inhibitor H89. Moreover, IGF-1 induced an increase in OAT3 phosphorylation, which was also blocked by H89. These data suggest that the IGF-1 modulation of OAT3 occurred through PKA signaling pathway. To further confirm the involvement of PKA, we treated OAT3-expressing cells with PKA activator Bt2-cAMP, followed by examining OAT activity and phosphorylation. We showed that OAT3 activity and phosphorylation were much enhanced in Bt2-cAMP-treated cells as compared to that in control cells. Finally, linsitinib, an anticancer drug that blocks the IGF-1 receptor, abrogated IGF-1-stimulated OAT3 transport activity. In conclusion, our study demonstrated that IGF-1 regulates OAT3 expression and transport activity through PKA signaling pathway, possibly by phosphorylating the transporter.

摘要

有机阴离子转运体3(OAT3)在从肾脏清除多种阴离子药物中起着至关重要的作用,从而避免它们在体内可能产生的毒性。在本研究中,我们调查了胰岛素样生长因子1(IGF-1)在OAT3调节中的作用。我们发现IGF-1以剂量和时间依赖性方式诱导OAT3转运活性增加,这与OAT3表达增加密切相关。IGF-1诱导的OAT3表达增加被蛋白激酶A(PKA)抑制剂H89阻断。此外,IGF-1诱导OAT3磷酸化增加,这也被H89阻断。这些数据表明IGF-1对OAT3的调节是通过PKA信号通路发生的。为了进一步证实PKA的参与,我们用PKA激活剂Bt2-cAMP处理表达OAT3的细胞,然后检测OAT活性和磷酸化。我们发现与对照细胞相比,Bt2-cAMP处理的细胞中OAT3活性和磷酸化显著增强。最后,一种阻断IGF-1受体的抗癌药物林西替尼消除了IGF-1刺激的OAT3转运活性。总之,我们的研究表明IGF-1通过PKA信号通路调节OAT3表达和转运活性,可能是通过使转运体磷酸化来实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/c027828223e9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/ef6ed627dd03/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/83c046a6fcb2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/683bb9d5c01a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/056a326b60f0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/c1d216a012f8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/f335cd36d51f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/cdb7e006091a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/c027828223e9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/ef6ed627dd03/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/83c046a6fcb2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/683bb9d5c01a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/056a326b60f0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/c1d216a012f8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/f335cd36d51f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/cdb7e006091a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/6977015/c027828223e9/gr7.jpg

相似文献

1
Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway.胰岛素样生长因子1通过蛋白激酶A信号通路调节有机阴离子转运体3的磷酸化、表达及活性。
Acta Pharm Sin B. 2020 Jan;10(1):186-194. doi: 10.1016/j.apsb.2019.05.005. Epub 2019 Jun 5.
2
Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3.蛋白激酶 A 的激活刺激有机阴离子转运蛋白 3 的 SUMOylation、表达和转运活性。
AAPS J. 2019 Feb 13;21(2):30. doi: 10.1208/s12248-019-0303-4.
3
Peptide Hormone Insulin Regulates Function, Expression, and SUMOylation of Organic Anion Transporter 3.肽激素胰岛素调节有机阴离子转运蛋白 3 的功能、表达和 SUMO 化。
AAPS J. 2021 Mar 11;23(2):41. doi: 10.1208/s12248-021-00575-z.
4
The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.SUMO 特异性蛋白酶 Senp2 调节人有机阴离子转运蛋白 3 的 SUMOylation、表达和功能。
Biochim Biophys Acta Biomembr. 2019 Jul 1;1861(7):1293-1301. doi: 10.1016/j.bbamem.2019.04.007. Epub 2019 May 1.
5
Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules.兔离体肾近端小管中OAT3介导的硫酸雌酮转运的急性调节
Am J Physiol Renal Physiol. 2004 Nov;287(5):F1021-9. doi: 10.1152/ajprenal.00080.2004. Epub 2004 Jul 6.
6
Modulation of the steroidogenic activity of luteinizing hormone by insulin and insulin-like growth factor-I through interaction with the cAMP-dependent protein kinase signaling pathway in the trout ovary.胰岛素和胰岛素样生长因子-I通过与虹鳟卵巢中cAMP依赖性蛋白激酶信号通路相互作用对促黄体生成素的类固醇生成活性进行调节。
Mol Cell Endocrinol. 2005 Jan 14;229(1-2):49-56. doi: 10.1016/j.mce.2004.09.006.
7
An Essential Role of Nedd4-2 in the Ubiquitination, Expression, and Function of Organic Anion Transporter-3.Nedd4-2在有机阴离子转运体-3的泛素化、表达及功能中的重要作用
Mol Pharm. 2016 Feb 1;13(2):621-30. doi: 10.1021/acs.molpharmaceut.5b00839. Epub 2015 Dec 22.
8
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].人顶端和基底外侧有机阴离子转运体(OAT)基因[OAT1(NKT)、OAT2、OAT3、OAT4、尿酸盐转运体(RST)]编码区多态性分析
Kidney Int. 2005 Oct;68(4):1491-9. doi: 10.1111/j.1523-1755.2005.00612.x.
9
Membrane trafficking of the human organic anion-transporting polypeptide C (hOATPC).人类有机阴离子转运多肽C(hOATPC)的膜运输
Pharm Res. 2008 Feb;25(2):463-74. doi: 10.1007/s11095-007-9399-9. Epub 2007 Jul 20.
10
Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.胰岛素样生长因子1通过磷脂酰肌醇3激酶/蛋白激酶A/c-Raf途径抑制细胞外信号调节激酶,以促进神经元存活。
J Neurosci. 2005 Mar 16;25(11):2838-52. doi: 10.1523/JNEUROSCI.5060-04.2005.

引用本文的文献

1
Palmitoylation Transduces the Regulation of Epidermal Growth Factor to Organic Anion Transporter 3.棕榈酰化介导表皮生长因子对有机阴离子转运体3的调控。
Pharmaceutics. 2025 Jun 25;17(7):825. doi: 10.3390/pharmaceutics17070825.
2
Taxifolin attenuates liver fibrosis by regulating the phosphorylation of NDRG1 at Thr328 hepatocyte-stellate cell cross talk.紫杉叶素通过调节NDRG1在苏氨酸328处的磷酸化来减弱肝星状细胞与肝细胞之间的相互作用,从而减轻肝纤维化。
Acta Pharm Sin B. 2025 Apr;15(4):2059-2076. doi: 10.1016/j.apsb.2025.02.017. Epub 2025 Feb 19.
3
The signaling landscape of insulin-like growth factor 1.

本文引用的文献

1
Role of the putative PKC phosphorylation sites of the type IIc sodium-dependent phosphate transporter in parathyroid hormone regulation.Ⅱc 型钠依赖性磷酸盐转运体假定蛋白激酶 C 磷酸化位点在甲状旁腺激素调节中的作用。
Clin Exp Nephrol. 2019 Jul;23(7):898-907. doi: 10.1007/s10157-019-01725-6. Epub 2019 Mar 21.
2
Acetylshikonin stimulates glucose uptake in L6 myotubes via a PLC-β3/PKCδ-dependent pathway.乙酰紫草素通过 PLC-β3/PKCδ 依赖途径刺激 L6 肌管摄取葡萄糖。
Biomed Pharmacother. 2019 Apr;112:108588. doi: 10.1016/j.biopha.2019.01.049. Epub 2019 Feb 16.
3
Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3.
胰岛素样生长因子1的信号转导格局
J Biol Chem. 2025 Jan;301(1):108047. doi: 10.1016/j.jbc.2024.108047. Epub 2024 Dec 3.
4
Recent Advances on the Regulations of Organic Anion Transporters.有机阴离子转运体调控的最新进展
Pharmaceutics. 2024 Oct 24;16(11):1355. doi: 10.3390/pharmaceutics16111355.
5
Topotecan and Ginkgolic Acid Inhibit the Expression and Transport Activity of Human Organic Anion Transporter 3 by Suppressing SUMOylation of the Transporter.拓扑替康和银杏酸通过抑制人有机阴离子转运体3的SUMO化来抑制其表达和转运活性。
Pharmaceutics. 2024 May 9;16(5):638. doi: 10.3390/pharmaceutics16050638.
6
Renal Organic Anion Transporters 1 and 3 In Vitro: Gone but Not Forgotten.肾脏有机阴离子转运体 1 和 3 的体外研究:虽已消逝,但并未被遗忘。
Int J Mol Sci. 2023 Oct 21;24(20):15419. doi: 10.3390/ijms242015419.
7
The regulation of human organic anion transporter 4 by insulin-like growth factor 1 and protein kinase B signaling.胰岛素样生长因子 1 和蛋白激酶 B 信号对人有机阴离子转运体 4 的调节。
Biochem Pharmacol. 2023 Sep;215:115702. doi: 10.1016/j.bcp.2023.115702. Epub 2023 Jul 23.
8
Pancreatic Hormone Insulin Modulates Organic Anion Transporter 1 in the Kidney: Regulation via Remote Sensing and Signaling Network.胰腺激素胰岛素调节肾脏中的有机阴离子转运蛋白 1:通过远程感应和信号网络的调节。
AAPS J. 2023 Jan 10;25(1):13. doi: 10.1208/s12248-022-00778-y.
9
Inhibition of proteasome, but not lysosome, upregulates organic anion transporter 3 in vitro and in vivo.蛋白酶体抑制而非溶酶体抑制可上调有机阴离子转运体 3 的体外和体内表达。
Biochem Pharmacol. 2023 Feb;208:115387. doi: 10.1016/j.bcp.2022.115387. Epub 2022 Dec 19.
10
Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium.药物转运蛋白的调控:从机制到临床影响——国际转运蛋白联合会白皮书
Clin Pharmacol Ther. 2022 Sep;112(3):461-484. doi: 10.1002/cpt.2605. Epub 2022 May 24.
蛋白激酶 A 的激活刺激有机阴离子转运蛋白 3 的 SUMOylation、表达和转运活性。
AAPS J. 2019 Feb 13;21(2):30. doi: 10.1208/s12248-019-0303-4.
4
Protein kinase Cα-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it.蛋白激酶 Cα介导的 Twist1 丝氨酸 144 位磷酸化可防止 Twist1 泛素化并使其稳定。
J Biol Chem. 2019 Mar 29;294(13):5082-5093. doi: 10.1074/jbc.RA118.005921. Epub 2019 Feb 7.
5
The systems biology of uric acid transporters: the role of remote sensing and signaling.尿酸转运体的系统生物学:远程传感和信号转导的作用。
Curr Opin Nephrol Hypertens. 2018 Jul;27(4):305-313. doi: 10.1097/MNH.0000000000000427.
6
AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3.AG490,一种 JAK2 特异性抑制剂,下调有机阴离子转运蛋白 3 的表达和活性。
J Pharmacol Sci. 2018 Mar;136(3):142-148. doi: 10.1016/j.jphs.2018.01.006. Epub 2018 Feb 8.
7
A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC).一项评估 OSI-906(一种胰岛素样生长因子受体-1 抑制剂)治疗无症状或轻度症状(非阿片类药物需求)转移性去势抵抗性前列腺癌(CRPC)患者的 II 期研究。
Invest New Drugs. 2018 Jun;36(3):451-457. doi: 10.1007/s10637-018-0574-0. Epub 2018 Feb 23.
8
Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.评估间歇性和连续性依维莫司与每周紫杉醇在铂类耐药复发性卵巢上皮癌患者中的 2 期研究。
Gynecol Oncol. 2018 May;149(2):275-282. doi: 10.1016/j.ygyno.2018.01.019. Epub 2018 Feb 14.
9
The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.SLC22 转运蛋白家族:药物转运蛋白对代谢途径、信号转导和疾病影响的范例。
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:663-687. doi: 10.1146/annurev-pharmtox-010617-052713.
10
PKC/Nedd4-2 Signaling Pathway Regulates the Cell Surface Expression of Drug Transporter hOAT1.蛋白激酶C/神经前体细胞表达发育下调蛋白4-2信号通路调控药物转运体hOAT1的细胞表面表达。
Drug Metab Dispos. 2017 Aug;45(8):887-895. doi: 10.1124/dmd.117.075861. Epub 2017 Jun 1.